• Je něco špatně v tomto záznamu ?

Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review

L. Vartolomei, M. Schmidinger, MD. Vartolomei, SF. Shariat

. 2022 ; 11 (21) : . [pub] 20221028

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22031423

(1) Background: The incidence of psychological distress and its impact on renal cell carcinoma (RCC) patients is unclear. Our aim was to analyze the literature regarding the prevalence of psychological distress and its impact on patients with non-metastatic or metastatic RCC; (2) Methods: A systematic search of five databases was performed. Studies were considered eligible if they included patients with RCC, had a prospective or retrospective design, and assessed anxiety, depression, or psychological distress at any time during treatment or follow-up. Exclusion criteria: no treatment for RCC, or not providing data for RCC patients; (3) Results: A total of 15 studies were included. Reported psychological distress was up to 77% and the prevalence of depressive and anxiety symptoms were up to 77.6% and 68.3% in patients with non-metastatic RCC. There was no association of depression with overall survival (OS) in patients with non-metastatic RCC treated by radical nephrectomy; on the contrary, in patients with metastatic disease, depression had an impact on OS. Limitations are related to the quality of the included studies; (4) Conclusions: Patients with RCC reported a high level of psychological distress like other cancer patients. It seems that for patients with localized disease, psychological distress does not impact OS, while it does in those with metastatic disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031423
003      
CZ-PrNML
005      
20230127131150.0
007      
ta
008      
230119s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcm11216383 $2 doi
035    __
$a (PubMed)36362610
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Vartolomei, Liliana $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria $u Institution Organizing University Doctoral Studies I.O.S.U.D, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology from Târgu Mureș, 540139 Târgu Mureș, Romania $1 https://orcid.org/0000000341023877
245    10
$a Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review / $c L. Vartolomei, M. Schmidinger, MD. Vartolomei, SF. Shariat
520    9_
$a (1) Background: The incidence of psychological distress and its impact on renal cell carcinoma (RCC) patients is unclear. Our aim was to analyze the literature regarding the prevalence of psychological distress and its impact on patients with non-metastatic or metastatic RCC; (2) Methods: A systematic search of five databases was performed. Studies were considered eligible if they included patients with RCC, had a prospective or retrospective design, and assessed anxiety, depression, or psychological distress at any time during treatment or follow-up. Exclusion criteria: no treatment for RCC, or not providing data for RCC patients; (3) Results: A total of 15 studies were included. Reported psychological distress was up to 77% and the prevalence of depressive and anxiety symptoms were up to 77.6% and 68.3% in patients with non-metastatic RCC. There was no association of depression with overall survival (OS) in patients with non-metastatic RCC treated by radical nephrectomy; on the contrary, in patients with metastatic disease, depression had an impact on OS. Limitations are related to the quality of the included studies; (4) Conclusions: Patients with RCC reported a high level of psychological distress like other cancer patients. It seems that for patients with localized disease, psychological distress does not impact OS, while it does in those with metastatic disease.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Schmidinger, Manuela $u Department of Urology & Comprehensive Cancer Center, Clinical Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria
700    1_
$a Vartolomei, Mihai Dorin $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria $u Institution Organizing University Doctoral Studies I.O.S.U.D, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology from Târgu Mureș, 540139 Târgu Mureș, Romania $1 https://orcid.org/0000000203598517
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria $u Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow 119435, Russia $u Department of Urology, Weill Cornell Medical College, New York, NY 1300, USA $u Department of Urology, University of Texas Southwestern, Dallas, TX 75390, USA $u Karl Landsteiner Institute of Urology and Andrology, 1090 Vienna, Austria $u Department of Urology, Second Faculty of Medicine, Charles University, 110 00 Prague, Czech Republic $u Hourani Center for Applied Scientific Research, Al Ahlizza Amman University, Amman 19328, Jordan
773    0_
$w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 11, č. 21 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36362610 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230119 $b ABA008
991    __
$a 20230127131142 $b ABA008
999    __
$a ok $b bmc $g 1889492 $s 1182756
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 11 $c 21 $e 20221028 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
LZP    __
$a Pubmed-20230119

Najít záznam

Citační ukazatele

Možnosti archivace